Pharmacometric and electrocardiographic evaluation of chloroquine and azithromycin in healthy volunteers
Chloroquine and azithromycin were developed in combination for the preventive treatment of malaria in pregnancy, and more recently were proposed as coronavirus disease 2019 (COVID-19) treatment options. Billions of doses of chloroquine have been administered worldwide over the past 70 years but conc...
Автори: | Chotsiri, P, Tarning, J, Hoglund, RM, Watson, JA, White, NJ |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
American Society for Clinical Pharmacology and Therapeutics
2022
|
Схожі ресурси
Схожі ресурси
-
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics
за авторством: Wattanakul, T, та інші
Опубліковано: (2022) -
Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
за авторством: Chotsiri, P, та інші
Опубліковано: (2017) -
Concentration-dependent mortality of chloroquine in overdose
за авторством: Watson, JA, та інші
Опубліковано: (2020) -
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
за авторством: White, NJ, та інші
Опубліковано: (2020) -
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
за авторством: Pukrittayakamee, S, та інші
Опубліковано: (2024)